Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Pharmaceuticals Novo Nordisk A/S Breaking News: Europe
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Bayer AG Europe Politics International: Top News And Analysis
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Politics Drug Retail Pharmaceuticals
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Social issues Health & Science Health care industry
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Business Roche Holding AG AstraZeneca PLC
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It: Next Gen Investing Make It Make It / Money
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Health & Science Health care industry Technology
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Arm Holdings PLC stocks Palantir Technologies Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Pfizer Inc Pharmaceuticals Mergers
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Biotech and Pharmaceuticals US: News Breaking News: Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Business Social issues Health & Science
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Pfizer Inc Bristol/Myers Squibb Co Health care industry
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Europe Markets Boeing Co Deutsche Lufthansa AG
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Novo Nordisk A/S Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Morgan Stanley Asia Markets Novo Nordisk A/S
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Biotechnology Novo Nordisk A/S Business News
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Novo Nordisk A/S Luxury Europe Markets
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Business Health & Science Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Compagnie Financiere Richemont SA US: News LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Roche Holding AG Bavarian Nordic A/S Novartis AG
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Breaking News: Business US: News LILLY DRN
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Europe Markets Market Outlook World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags SAP AG Tesla Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Health care industry Health & Science Social issues
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Europe Markets Novo Nordisk A/S Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Business News Biotechnology Structure Therapeutics Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.